Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

tella Inc lowers consolidated mid-year and full-year outlook for FY 2014


Friday, 1 Aug 2014 02:30am EDT 

tella Inc:Says the company lowered the consolidated mid-year outlook for revenue to 1,031 million yen from 1,067 million yen for the fiscal year ending Dec. 2014.Sees a decrease of operating profit forecast to a loss of 105 million yen from a loss of 78 million yen.Sees a decrease of ordinary profit forecast to a loss of 125 million yen from a loss of 95 million yen.Sees a decrease of net profit forecast to a loss of 129 million yen from a loss of 97 million yen.Sees a decrease of earnings per share to a loss of 9.44 yen from a loss of 7.38 yen.Says the company lowered the consolidated full-year outlook for revenue to 2,040 million yen from 2,090 million yen for the fiscal year ending Dec. 2014.Sees a decrease of operating profit forecast to a loss of 316 million yen from a loss of 135 million yen.Sees a decrease of ordinary profit forecast to a loss of 351 million yen from a loss of 156 million yen.Sees a decrease of net profit forecast to a loss of 324 million yen from a loss of 154 million yen.Sees a decrease of earnings per share to a loss of 23.53 yen from a loss of 11.68 yen.FY 2014 revenues of 2 billion yen, reported net profit of a loss of 0.15 billion yen – Thomson Reuters I/B/E/S.Comments the decreased revenue in cell therapy business and start-up costs of new business are the main reasons for the forecast. 

Company Quote

1542.0
 --
27 May 2015